AAPL295.78+1.48 (+0.50%) ▲|ABBV232.95-1.81 (-0.77%) ▼|ABT91.04+0.51 (+0.56%) ▲|ACN130.14+3.13 (+2.46%) ▲|ADBE198.39+0.96 (+0.48%) ▲|AMAT576.22-9.67 (-1.65%) ▼|AMD511.06-8.79 (-1.69%) ▼|AMGN350.88+3.87 (+1.12%) ▲|AMT175.12-4.26 (-2.37%) ▼|AMZN238.39+4.28 (+1.83%) ▲|AVGO380.31+0.16 (+0.04%) ▲|AXP342.13+4.35 (+1.29%) ▲|BA220.16+3.45 (+1.59%) ▲|BAC57.63-0.29 (-0.49%) ▼|BKNG184.26+15.32 (+9.07%) ▲|BLK987.12-28.21 (-2.78%) ▼|BMY54.98-0.56 (-1.00%) ▼|BNY144.65-2.64 (-1.79%) ▼|BRK-B495.72+2.91 (+0.59%) ▲|C143.72-1.25 (-0.86%) ▼|CAT980.30-3.94 (-0.40%) ▼|CL92.36+0.93 (+1.01%) ▲|CMCSA22.64-0.17 (-0.72%) ▼|COF201.39+3.58 (+1.81%) ▲|COP107.02-2.95 (-2.68%) ▼|COST962.04+4.36 (+0.45%) ▲|CRM153.77+0.35 (+0.22%) ▲|CSCO119.51-1.64 (-1.35%) ▼|CVS101.00-0.57 (-0.56%) ▼|CVX171.72-4.26 (-2.42%) ▼|DE606.31+14.37 (+2.43%) ▲|DHR188.59+9.62 (+5.38%) ▲|DIS101.98-1.56 (-1.50%) ▼|DUK125.43+0.38 (+0.30%) ▲|EMR141.53-1.62 (-1.13%) ▼|FDX312.94-4.30 (-1.36%) ▼|GD345.24-5.10 (-1.46%) ▼|GE365.89+9.42 (+2.64%) ▲|GEV1,050.11+15.13 (+1.46%) ▲|GILD125.46+0.41 (+0.33%) ▲|GM79.56+0.61 (+0.77%) ▲|GOOG348.20+2.12 (+0.61%) ▲|GOOGL348.77+2.68 (+0.78%) ▲|GS1,077.11-17.33 (-1.58%) ▼|HD340.10+15.65 (+4.82%) ▲|HON227.45+5.08 (+2.28%) ▲|IBM263.11-1.83 (-0.69%) ▼|INTC129.93-2.35 (-1.78%) ▼|INTU267.41+9.36 (+3.63%) ▲|ISRG403.34+0.16 (+0.04%) ▲|JNJ239.32+0.24 (+0.10%) ▲|JPM332.92-1.22 (-0.36%) ▼|KO80.96+0.65 (+0.81%) ▲|LIN518.44+6.18 (+1.21%) ▲|LLY1,106.74-0.34 (-0.03%) ▼|LMT495.39-8.28 (-1.64%) ▼|LOW220.69+7.15 (+3.35%) ▲|LRCX364.19-7.15 (-1.92%) ▼|MA495.58+7.51 (+1.54%) ▲|MCD274.73+3.07 (+1.13%) ▲|MDLZ62.01+0.95 (+1.56%) ▲|MDT80.54-0.09 (-0.11%) ▼|META557.77-4.43 (-0.79%) ▼|MMM166.15+4.31 (+2.66%) ▲|MO71.83+0.22 (+0.31%) ▲|MRK120.42+0.82 (+0.69%) ▲|MS220.49-5.54 (-2.45%) ▼|MSFT371.61-2.34 (-0.62%) ▼|MU1,019.18-32.59 (-3.10%) ▼|NEE87.09+0.66 (+0.76%) ▲|NFLX72.61-0.22 (-0.30%) ▼|NKE41.92-0.47 (-1.10%) ▼|NOW93.96-1.98 (-2.06%) ▼|NVDA197.84-2.16 (-1.08%) ▼|ORCL156.86-8.31 (-5.03%) ▼|PEP142.23+0.18 (+0.13%) ▲|PFE23.98-0.75 (-3.01%) ▼|PG152.30+1.44 (+0.95%) ▲|PLTR113.11-3.59 (-3.08%) ▼|PM177.55-1.14 (-0.64%) ▼|QCOM194.81-9.32 (-4.57%) ▼|RTX185.70-0.69 (-0.37%) ▼|SBUX103.83+2.78 (+2.75%) ▲|SCHW91.79-1.38 (-1.48%) ▼|SO95.02+0.09 (+0.09%) ▲|SPG220.17+3.43 (+1.58%) ▲|T22.43-0.38 (-1.67%) ▼|TMO489.80+20.45 (+4.36%) ▲|TMUS182.73-1.84 (-1.00%) ▼|TSLA374.43-7.18 (-1.88%) ▼|TXN302.96-1.40 (-0.46%) ▼|UBER73.72+4.05 (+5.81%) ▲|UNH403.45-5.80 (-1.42%) ▼|UNP259.96+1.35 (+0.52%) ▲|UPS104.88-0.95 (-0.90%) ▼|USB60.12+0.07 (+0.12%) ▲|V332.90+4.42 (+1.34%) ▲|VZ45.62-1.12 (-2.39%) ▼|WFC84.12-0.01 (-0.01%) ▼|WMT119.48+0.06 (+0.05%) ▲|XOM136.37-3.36 (-2.40%) ▼|AAPL295.78+1.48 (+0.50%) ▲|ABBV232.95-1.81 (-0.77%) ▼|ABT91.04+0.51 (+0.56%) ▲|ACN130.14+3.13 (+2.46%) ▲|ADBE198.39+0.96 (+0.48%) ▲|AMAT576.22-9.67 (-1.65%) ▼|AMD511.06-8.79 (-1.69%) ▼|AMGN350.88+3.87 (+1.12%) ▲|AMT175.12-4.26 (-2.37%) ▼|AMZN238.39+4.28 (+1.83%) ▲|AVGO380.31+0.16 (+0.04%) ▲|AXP342.13+4.35 (+1.29%) ▲|BA220.16+3.45 (+1.59%) ▲|BAC57.63-0.29 (-0.49%) ▼|BKNG184.26+15.32 (+9.07%) ▲|BLK987.12-28.21 (-2.78%) ▼|BMY54.98-0.56 (-1.00%) ▼|BNY144.65-2.64 (-1.79%) ▼|BRK-B495.72+2.91 (+0.59%) ▲|C143.72-1.25 (-0.86%) ▼|CAT980.30-3.94 (-0.40%) ▼|CL92.36+0.93 (+1.01%) ▲|CMCSA22.64-0.17 (-0.72%) ▼|COF201.39+3.58 (+1.81%) ▲|COP107.02-2.95 (-2.68%) ▼|COST962.04+4.36 (+0.45%) ▲|CRM153.77+0.35 (+0.22%) ▲|CSCO119.51-1.64 (-1.35%) ▼|CVS101.00-0.57 (-0.56%) ▼|CVX171.72-4.26 (-2.42%) ▼|DE606.31+14.37 (+2.43%) ▲|DHR188.59+9.62 (+5.38%) ▲|DIS101.98-1.56 (-1.50%) ▼|DUK125.43+0.38 (+0.30%) ▲|EMR141.53-1.62 (-1.13%) ▼|FDX312.94-4.30 (-1.36%) ▼|GD345.24-5.10 (-1.46%) ▼|GE365.89+9.42 (+2.64%) ▲|GEV1,050.11+15.13 (+1.46%) ▲|GILD125.46+0.41 (+0.33%) ▲|GM79.56+0.61 (+0.77%) ▲|GOOG348.20+2.12 (+0.61%) ▲|GOOGL348.77+2.68 (+0.78%) ▲|GS1,077.11-17.33 (-1.58%) ▼|HD340.10+15.65 (+4.82%) ▲|HON227.45+5.08 (+2.28%) ▲|IBM263.11-1.83 (-0.69%) ▼|INTC129.93-2.35 (-1.78%) ▼|INTU267.41+9.36 (+3.63%) ▲|ISRG403.34+0.16 (+0.04%) ▲|JNJ239.32+0.24 (+0.10%) ▲|JPM332.92-1.22 (-0.36%) ▼|KO80.96+0.65 (+0.81%) ▲|LIN518.44+6.18 (+1.21%) ▲|LLY1,106.74-0.34 (-0.03%) ▼|LMT495.39-8.28 (-1.64%) ▼|LOW220.69+7.15 (+3.35%) ▲|LRCX364.19-7.15 (-1.92%) ▼|MA495.58+7.51 (+1.54%) ▲|MCD274.73+3.07 (+1.13%) ▲|MDLZ62.01+0.95 (+1.56%) ▲|MDT80.54-0.09 (-0.11%) ▼|META557.77-4.43 (-0.79%) ▼|MMM166.15+4.31 (+2.66%) ▲|MO71.83+0.22 (+0.31%) ▲|MRK120.42+0.82 (+0.69%) ▲|MS220.49-5.54 (-2.45%) ▼|MSFT371.61-2.34 (-0.62%) ▼|MU1,019.18-32.59 (-3.10%) ▼|NEE87.09+0.66 (+0.76%) ▲|NFLX72.61-0.22 (-0.30%) ▼|NKE41.92-0.47 (-1.10%) ▼|NOW93.96-1.98 (-2.06%) ▼|NVDA197.84-2.16 (-1.08%) ▼|ORCL156.86-8.31 (-5.03%) ▼|PEP142.23+0.18 (+0.13%) ▲|PFE23.98-0.75 (-3.01%) ▼|PG152.30+1.44 (+0.95%) ▲|PLTR113.11-3.59 (-3.08%) ▼|PM177.55-1.14 (-0.64%) ▼|QCOM194.81-9.32 (-4.57%) ▼|RTX185.70-0.69 (-0.37%) ▼|SBUX103.83+2.78 (+2.75%) ▲|SCHW91.79-1.38 (-1.48%) ▼|SO95.02+0.09 (+0.09%) ▲|SPG220.17+3.43 (+1.58%) ▲|T22.43-0.38 (-1.67%) ▼|TMO489.80+20.45 (+4.36%) ▲|TMUS182.73-1.84 (-1.00%) ▼|TSLA374.43-7.18 (-1.88%) ▼|TXN302.96-1.40 (-0.46%) ▼|UBER73.72+4.05 (+5.81%) ▲|UNH403.45-5.80 (-1.42%) ▼|UNP259.96+1.35 (+0.52%) ▲|UPS104.88-0.95 (-0.90%) ▼|USB60.12+0.07 (+0.12%) ▲|V332.90+4.42 (+1.34%) ▲|VZ45.62-1.12 (-2.39%) ▼|WFC84.12-0.01 (-0.01%) ▼|WMT119.48+0.06 (+0.05%) ▲|XOM136.37-3.36 (-2.40%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: patients

Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025

COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

Brain Navi Biotechnology’s NaoTrac performs first surgeries in Spain

Brain Navi has officially landed in Spain! TAIPEI, Aug.11, 2025 /PRNewswire/ -- Such an achievement has been made possible through the first of many collaborations...

AMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus

SEOUL, South Korea, Aug. 11, 2025 /PRNewswire/ -- AMI Pharm, a biotechnology company focused on aesthetic and therapeutic innovations, announced today that its lead candidate,...

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in...

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025 

Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy

HONG KONG, Aug. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its multicenter,...

60 Global Rising Stars from 1,200 Universities will Converge in Singapore for SMU’s 12th Lee Kuan Yew Competition Grand Finals

60 finalists for SG60 milestone edition selected by an international panel of judges and visionary partnersFocus on empowering Urban Solutions and Sustainability to solve...

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients